(2R)-1-[4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]furo[3,2-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide
C23H25N7O5 — CID 142498497
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-1-[4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]furo[3,2-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide
(2R)-1-[4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]furo[3,2-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide (PubChem CID 142498497) has the molecular formula C23H25N7O5 and a molecular weight of 479.50 g/mol. Its IUPAC name is (2R)-1-[4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]furo[3,2-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2R)-1-[4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]furo[3,2-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 142498497 |
| Molecular Formula | C23H25N7O5 |
| Molecular Weight | 479.50 g/mol |
| Exact Mass | 479.19 |
| IUPAC Name | (2R)-1-[4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]furo[3,2-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide |
| SMILES | COc1cc(-n2cnc(Nc3nc(N4CCC[C@@H]4C(N)=O)nc4ccoc34)c2)cc(OC)c1OC |
| InChI | InChI=1S/C23H25N7O5/c1-32-16-9-13(10-17(33-2)20(16)34-3)29-11-18(25-12-29)27-22-19-14(6-8-35-19)26-23(28-22)30-7-4-5-15(30)21(24)31/h6,8-12,15H,4-5,7H2,1-3H3,(H2,24,31)(H,26,27,28)/t15-/m1/s1 |
| InChIKey | NBAWYUWGNQTARU-OAHLLOKOSA-N |
| XLogP | 2.63 |
| TPSA | 142.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 479.50 |
| LogP ≤ 5 | 2.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142498497 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.